0001628280-26-015079
SEC filingThe provided document section is ITEM 7 (Major Shareholders and Related Party Transactions), not MD&A; no financial analysis available.
Stratasys Ltd. is a global leader in polymer-based 3D printing solutions, providing systems, consumables, software, and services at every stage of the product life cycle. The company focuses on industrial, healthcare, and consumer fields, with a particular emphasis on polymer 3D printing solutions for the fastest-growing industrial and healthcare applications. Stratasys holds approximately 2,700 granted and pending additive technology patents and has dual headquarters in Rehovot, Israel and Minnetonka, Minnesota.
The Business section does not explicitly define separate reporting segments. The company describes its operations as providing additive manufacturing systems, related consumables, and services, including its Stratasys Direct Manufacturing (SDM) parts service. No revenue share by segment is disclosed in this section.
Stratasys offers a broad portfolio of 3D printing platforms and technologies. Key platforms include the P3™ Programmable PhotoPolymerization technology (acquired via Origin), which precisely controls light, heat, and force to produce parts with exceptional accuracy. The Neo® line of stereolithography systems features dynamic laser beam technology and is an open resin system. The Stratasys H350™ 3D printer, powered by SAF™ powder-based technology, is designed for cost-competitive parts at production-level throughput. The company also offers PolyJet 3D printers (using printer heads from sole supplier Ricoh), FDM manufacturing systems, and the GrabCAD® additive manufacturing platform. The IAM Marketplace is an open materials ecosystem. The company's materials portfolio was bolstered by acquisitions of Covestro’s additive manufacturing materials business, Forward AM Technologies, and assets of Nexa3D.
Stratasys relies heavily on a network of resellers and independent sales agents to sell and service its products for end-users in their respective geographic regions. The company also has a direct sales force and operates its Stratasys Direct Manufacturing services business. No single customer concentration is disclosed in this section. In 2025, 40.3% of revenues came from countries outside the Americas.
The company faces competition from a wide variety of producers of 3D printing systems, materials, and services. Named competitors for 3D systems include Formlabs, 3D Systems Corporation, Carbon, HP, EOS GmbH, Markforged, Desktop Metal, and Bambu Lab. For its AM parts and services business, leading competitors include 3D Systems, Materialise, Protolabs, and other service providers. The filing notes that some competitors have longer operating histories, greater name recognition, and more financial, marketing, and distribution resources.
Stratasys's stated strategic priorities include strengthening its position in polymers and the fast-growing mass production parts market, expanding its polymer suite of solutions across the product life cycle, and providing a complete portfolio offering within additive manufacturing in polymers and metals (the 'North Star' strategy). The company focuses on the highest growth potential use cases, products, materials, and software solutions, and aims to deepen relationships with leading OEMs in key manufacturing use cases such as dental, automotive, consumer goods, and aerospace.
The Business section does not disclose total employee headcount. It notes that the company reduced its workforce by approximately 15% in the last four months of 2024 as part of a restructuring program, and that the Core Leadership Team was reduced and dispersed among the U.S., Germany, and Israel.
The provided document content corresponds to ITEM 7 (Major Shareholders and Related Party Transactions) of the 20-F filing, not the Management's Discussion and Analysis (MD&A) section. Consequently, there is no discussion of revenue, margins, segment performance, guidance, or other financial metrics typical of an MD&A. The text focuses on ownership structure, changes in major shareholders, and related party transactions such as the PIPE investment by Fortissimo and the Tritone Technologies investment. No financial analysis or forward-looking statements regarding operational performance are present. To perform the intended MD&A analysis, the actual MD&A section (e.g., Item 5) would need to be provided.
As of December 31, 2025, the company held $94.5 million in cash and cash equivalents and $150.0 million in short-term bank deposits, totaling $244.5 million in highly liquid assets. This compares to $70.2 million and $80.5 million, respectively, at year-end 2024. The increase was primarily driven by $119.3 million in net proceeds from a PIPE transaction completed during 2025. The company has no debt on its balance sheet. Shareholders' equity stood at $842.9 million, up from $793.0 million at the end of 2024, reflecting the PIPE issuance and share-based compensation, partially offset by a net loss of $104.3 million. Inventory decreased to $145.2 million from $179.8 million, a reduction of $34.6 million. Deferred revenue (short- and long-term) totaled $66.9 million, relatively flat year-over-year.
The Notes do not disclose any material purchase commitments, supply agreements, or capacity reservation obligations. The company has operating lease liabilities of $26.5 million (current and non-current) related to facilities and vehicles, with the latest lease expiring in December 2044. Contingent consideration liabilities from business combinations totaled $5.4 million as of December 31, 2025. The company is party to various legal proceedings but has recorded provisions only for amounts judged to be both quantifiable and probable.
On September 16, 2024, the board authorized a $50 million share repurchase program. During 2024, the company repurchased 266,018 shares at an average price of $7.50 per share for $2.0 million, leaving $48.0 million of authorization remaining as of December 31, 2024. No repurchases were made in 2025. The company has never paid cash dividends and does not anticipate doing so in the foreseeable future. Capital expenditures were $22.1 million in 2025, up from $10.9 million in 2024. No debt was issued or repaid. The company also paid $1.1 million in contingent consideration related to prior acquisitions.
The company operates as a single operating segment. The Notes do not provide segment-level revenue or operating income breakdowns. Geographic revenue detail is limited to export sales: total export sales (to customers outside North America and Israel) were $223.2 million in 2025, representing 40.5% of total sales of $551.1 million. This compares to $230.6 million (40.3% of sales) in 2024 and $228.9 million (36.5%) in 2023. The company's dual headquarters are in Israel and the United States, with significant operations also in Germany, Hong Kong, and Japan.
The provided document excerpt contains only the audit opinion and index, not the actual cash flow statement figures. Therefore, no quantitative cash flow data can be extracted.